Simplex Trading
CPRX

Simplex Trading’s Catalyst Pharmaceutical CPRX Stock Holding History

Simplex Trading’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$461K Buy
+18,600
New +$443K ﹤0.01% 3360
2025
Q4 		– Sell
-8,800
Closed -$173K – 8768
2025
Q3 		$173K Buy
8,800
+800
+10% +$16.5K ﹤0.01% 5116
2025
Q2 		$173K Buy
8,000
+6,400
+400% +$151K ﹤0.01% 4654
2025
Q1 		$38K Buy
1,600
+1,400
+700% +$31.5K ﹤0.01% 6044
2024
Q4 		$4K Sell
200
-2,800
-93% -$60.2K ﹤0.01% 7712
2024
Q3 		$59K Buy
3,000
+2,700
+900% +$50.1K ﹤0.01% 5742
2024
Q2 		$4K Sell
300
-30,700
-99% -$478K ﹤0.01% 7963
2024
Q1 		$494K Buy
+31,000
New +$467K ﹤0.01% 3875
2023
Q4 		– Sell
-1,600
Closed -$18K – 8908
2023
Q3 		$18K Sell
1,600
-12,200
-88% -$163K ﹤0.01% 6698
2023
Q2 		$185K Buy
13,800
+7,500
+119% +$108K ﹤0.01% 4382
2023
Q1 		$104K Buy
6,300
+1,000
+19% +$16.5K ﹤0.01% 5107
2022
Q4 		$98K Sell
5,300
-25,100
-83% -$386K ﹤0.01% 5094
2022
Q3 		$390K Buy
30,400
+29,300
+2,664% +$347K ﹤0.01% 3757
2022
Q2 		$7K Sell
1,100
-32,900
-97% -$241K ﹤0.01% 8565
2022
Q1 		$281K Buy
34,000
+33,200
+4,150% +$235K ﹤0.01% 4638
2021
Q4 		$5K Sell
800
-83,400
-99% -$548K ﹤0.01% 9500
2021
Q3 		$487K Hold
84,200
– – ﹤0.01% 4146
2021
Q2 		$484K Buy
84,200
+84,065
+62,270% +$434K ﹤0.01% 4223
2021
Q1 		$62K Sell
135
-31
-19% -$123 ﹤0.01% 6342
2020
Q4 		$55K Buy
166
+58
+54% +$195 ﹤0.01% 6068
2020
Q3 		$32K Sell
108
-25
-19% -$98 ﹤0.01% 6005
2020
Q2 		$61K Buy
133
+29
+28% +$130 ﹤0.01% 5309
2020
Q1 		$40K Buy
104
+5
+5% +$21 ﹤0.01% 5354
2019
Q4 		$37K Sell
99
-183
-65% -$856 ﹤0.01% 5466
2019
Q3 		$149K Sell
282
-211
-43% -$1.12K ﹤0.01% 3876
2019
Q2 		$189K Sell
493
-13
-3% -$56 ﹤0.01% 3515
2019
Q1 		$258K Buy
+506
New +$1.49K ﹤0.01% 3332
2018
Q4 		– Sell
-4
Closed -$1K – 7097
2018
Q3 		$1K Buy
+4
New +$13 ﹤0.01% 7176

Other funds holding CPRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Simplex Trading's CPRX Position: Q1 2026 in Review

Simplex Trading opened a new position in Catalyst Pharmaceutical (CPRX) in Q1 2026: 3,811 shares worth $94.4K. The stake represents ﹤0.01% of the portfolio and ranks #5153 among its holdings. This is a return to the name: Simplex Trading previously reported a position in CPRX as recently as Q2 2025.

Simplex Trading first reported a position in CPRX in Q4 2014 and has held it in 30 quarters since. The position peaked at $448K in Q3 2021. 380 funds tracked by Wall St. Rank hold CPRX as of Q1 2026.

  • Simplex Trading held 3,811 shares of Catalyst Pharmaceutical worth $94.4K as of Q1 2026.
  • Catalyst Pharmaceutical was a new Simplex Trading position in Q1 2026.
  • Catalyst Pharmaceutical made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #5153 holding.
  • Simplex Trading first reported a position in Catalyst Pharmaceutical in Q4 2014 and has held it in 30 quarters since.
  • Simplex Trading's Catalyst Pharmaceutical position peaked at $448K in Q3 2021.
  • 380 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.